These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2731673)

  • 1. Pharmacokinetics, tissue distribution, and placental permeability of all-trans- and 13-cis-N-ethyl retinamides in pregnant hamsters.
    Howard WB; Willhite CC; Omaye ST; Sharma RP
    Fundam Appl Toxicol; 1989 Apr; 12(3):621-7. PubMed ID: 2731673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative distribution, pharmacokinetics and placental permeabilities of all-trans-retinoic acid, 13-cis-retinoic acid, all-trans-4-oxo-retinoic acid, retinyl acetate and 9-cis-retinal in hamsters.
    Howard WB; Willhite CC; Omaye ST; Sharma RP
    Arch Toxicol; 1989; 63(2):112-20. PubMed ID: 2730336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of retinoids in developmental toxicology. I. Studies on the nature of the polar terminus of the vitamin A molecule.
    Willhite CC; Dawson MI; Williams KJ
    Toxicol Appl Pharmacol; 1984 Jul; 74(3):397-410. PubMed ID: 6740687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retinoid metabolism and transplacental pharmacokinetics in the cynomolgus monkey following a nonteratogenic dosing regimen with all-trans-retinoic acid.
    Tzimas G; Nau H; Hendrickx AG; Peterson PE; Hummler H
    Teratology; 1996 Nov; 54(5):255-65. PubMed ID: 9035347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenicity and placental transfer of all-trans-, 13-cis-, 4-oxo-all-trans-, and 4-oxo-13-cis-retinoic acid after administration of a low oral dose during organogenesis in mice.
    Creech Kraft J; Löfberg B; Chahoud I; Bochert G; Nau H
    Toxicol Appl Pharmacol; 1989 Aug; 100(1):162-76. PubMed ID: 2763297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of urinary bladder cancer by N-(ethyl)-all-trans-retinamide and N-(2-hydroxyethyl)-all-trans-retinamide in rats and mice.
    Thompson HJ; Becci PJ; Grubbs CJ; Shealy YF; Stanek EJ; Brown CC; Sporn MB; Moon RC
    Cancer Res; 1981 Mar; 41(3):933-6. PubMed ID: 7459880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinamides: hydrolytic conversion of retinoylglycine to retinoic acid in pregnant mice contributes to teratogenicity.
    Kochhar DM; Shealy YF; Penner JD; Jiang H
    Teratology; 1992 Feb; 45(2):175-85. PubMed ID: 1615427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subacute toxicity of all-trans- and 13-cis-isomers of N-ethyl retinamide, N-2-hydroxyethyl retinamide, and N-4-hydroxyphenyl retinamide.
    Sani BP; Meeks RG
    Toxicol Appl Pharmacol; 1983 Sep; 70(2):228-35. PubMed ID: 6226123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low teratogenicity of 13-cis-retinoic acid (isotretinoin) in the mouse corresponds to low embryo concentrations during organogenesis: comparison to the all-trans isomer.
    Kraft JC; Kochhar DM; Scott WJ; Nau H
    Toxicol Appl Pharmacol; 1987 Mar; 87(3):474-82. PubMed ID: 3470977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The high sensitivity of the rabbit to the teratogenic effects of 13-cis-retinoic acid (isotretinoin) is a consequence of prolonged exposure of the embryo to 13-cis-retinoic acid and 13-cis-4-oxo-retinoic acid, and not of isomerization to all-trans-retinoic acid.
    Tzimas G; Bürgin H; Collins MD; Hummler H; Nau H
    Arch Toxicol; 1994; 68(2):119-28. PubMed ID: 8179481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic assessment of teratologically effective concentrations of an endogenous retinoic acid metabolite.
    Satre MA; Penner JD; Kochhar DM
    Teratology; 1989 Apr; 39(4):341-8. PubMed ID: 2749577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of murine hepatocarcinogenesis by all-trans-retinoic acid and two synthetic retinamides.
    McCormick DL; Hollister JL; Bagg BJ; Long RE
    Carcinogenesis; 1990 Sep; 11(9):1605-9. PubMed ID: 2144795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. All-trans-retinoic acid in maternal plasma and teratogenicity in rats and rabbits.
    Tembe EA; Honeywell R; Buss NE; Renwick AG
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):456-72. PubMed ID: 8975771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, tissue distribution and placental permeability of tetrahydro-tetramethyl-naphthalenyl-propenyl benzoic acid (a retinoidal benzoic acid derivative) in hamsters.
    Howard WB; Willhite CC; Sharma RP; Omaye ST; Hatori A
    Eur J Drug Metab Pharmacokinet; 1989; 14(2):153-9. PubMed ID: 2591420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative teratology and transplacental pharmacokinetics of all-trans-retinoic acid, 13-cis-retinoic acid, and retinyl palmitate following daily administrations in rats.
    Collins MD; Tzimas G; Hummler H; Bürgin H; Nau H
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):132-44. PubMed ID: 8048045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative disposition, receptor affinity, and teratogenic activity of sulfon arotinoids.
    Willhite CC; Dubois A; Schindler-Horvat J; Apfel C; Eckhoff C
    Teratology; 1995 Sep; 52(3):169-75. PubMed ID: 8638257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative teratogenic activity of cancer chemopreventive retinoidal benzoic acid congeners (arotinoids).
    Flanagan JL; Willhite CC; Ferm VH
    J Natl Cancer Inst; 1987 Mar; 78(3):533-8. PubMed ID: 3469465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isotretinoin (13-cis-retinoic acid) metabolism, cis-trans isomerization, glucuronidation, and transfer to the mouse embryo: consequences for teratogenicity.
    Creech Kraft J; Eckhoff C; Kochhar DM; Bochert G; Chahoud I; Nau H
    Teratog Carcinog Mutagen; 1991; 11(1):21-30. PubMed ID: 1677495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Teratogenicity and transplacental pharmacokinetics of 13-cis-retinoic acid in rabbits.
    Eckhoff C; Chari S; Kromka M; Staudner H; Juhasz L; Rudiger H; Agnish N
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):34-41. PubMed ID: 8128493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of embryotoxicity by structural modification of the terminal group of cancer chemopreventive retinoids.
    Willhite CC; Shealy YF
    J Natl Cancer Inst; 1984 Mar; 72(3):689-95. PubMed ID: 6583452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.